Full title: Cost-utility analysis of asenapine versus olanzapine in the treatment of bipolar disorder type I
Authors (in alphabetical order): Iván Castilla Rodríguez, Leticia Cuéllar-Pompa, Lidia García Pérez, Lilisbeth Perestelo Pérez, Pilar Pinilla Domínguez, Juan Manuel Ramos Goñi, Pedro Serrano Aguilar, Cristina Valcárcel Nazco
Contact person: Juan Manuel Ramos Goñi
Objectives
To compare the efficiency of asenapine versus olanzapine (Generic Pharmaceutical Specialty – EFG) in the treatment of manic episodes in bipolar disorder type I, from both the perspective of the National Health System (SNS) and the societal perspective.